SCHEMBL2862300

SCHEMBL2862300

O=C(O)c1cc2c(-c3ccc4ccccc4c3)n[nH]c2cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
CA12 O43570 1/20 0.47
CDK4 P11802 1/20 0.46
CCNA2 P20248 1/20 0.46
CCND1 P24385 1/20 0.46
CDK2 P24941 1/20 0.46
CCND3 P30281 1/20 0.46
KDR P35968 1/20 0.46
MAP2K4 P45985 7/20 0.45
MAPK1 P28482 4/20 0.45
MAPK6 Q16659 4/20 0.45
ACMSD Q8TDX5 1/20 0.45
PRKAB2 O43741 1/20 0.45
PRKAG1 P54619 1/20 0.45
PRKAA2 P54646 1/20 0.45
PRKAA1 Q13131 1/20 0.45
PRKAG3 Q9UGI9 1/20 0.45
PRKAG2 Q9UGJ0 1/20 0.45
PRKAB1 Q9Y478 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2867207 0.82 KDR (0.48) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL2857674 0.82 MAP2K4 (0.60) MAP2K4MAPK1MAPK6PRKAB2PRKAG1
SCHEMBL2858040 0.82 CDK4 (0.60) CA12CDK4CCNA2CCND1CDK2
SCHEMBL2864582 0.79 CDK2 (0.47) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL2864682 0.79 MAPKAPK2 (0.50) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL2857443 0.79 CA12 (0.46) MEN1KMT2ACA12CDK4CCNA2
SCHEMBL2862999 0.79 MAPK10 (0.47) CA12MAP2K4MAPK1MAPK6PRKAB2
SCHEMBL2863485 0.79 CDK4 (0.46) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL4334040 0.78 ROCK2 (0.41) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL13198220 0.78 DHODH (0.46) MEN1KMT2ACA12CDK4CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MEN1 3782/4885KMT2A 2212/4885CA12 3758/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MEN1 4417/4885KMT2A 2834/4885CA12 3727/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MEN1 3782/4885KMT2A 2212/4885CA12 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.